| Male | Female | ||||||
---|---|---|---|---|---|---|---|---|
 | Always | Frequently | Infrequently | Never | Always | Frequently | Infrequently | Never |
General prescribing | 22Â % (37/167) | 46Â % (77/167) | 25Â % (41/167) | 7Â % (11/167) | 21Â % (40/190) | 51Â % (97/190) | 22Â % (42/190) | 6Â % (12/190) |
In the case of a treatment failure | 68Â % (114/168) | 29Â % (49/168) | 2Â % (3/168) | 1Â % (1/168) | 79Â % (154/195) | 19Â % (38/195) | 1Â % (2/195) | 1Â % (1/195) |
When resistance is reported to initial prescribed agent | 81Â % (136/168) | 16Â % (27/168) | 2Â % (4/168) | 1Â % (1/168) | 86Â % (168/195) | 13Â % (26/195) | 1Â % (1/195) | 0Â % (0/195) |